Adams Cobi, Sawhney Gagandeep, Singh Kuljit
Department of Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD, 4029, Australia.
Faculty of Medicine, University of Queensland, Brisbane, QLD, 4029, Australia.
Heart Vessels. 2022 Apr;37(4):705-710. doi: 10.1007/s00380-021-01956-2. Epub 2021 Oct 10.
Most prior studies have compared myocardial infarction with non-obstructive coronary arteries (MINOCA), to obstructive acute coronary syndrome (ACS) often requiring revascularisation. However, these were subject to treatment bias given the significant differences in management. This study uniquely compares the management and outcomes of MINOCA patients with a medically managed obstructive ACS (M-ACS) population. We retrospectively analysed registry data for consecutive patients admitted to the Gold Coast University Hospital with ACS requiring coronary angiography and identified patients with MINOCA and M-ACS. Baseline characteristics, pharmacological therapy and in-hospital outcomes were compared. In hospital outcomes were composite NACE, heart failure, stroke and major bleeding. Multivariate regression analysis was also performed to identify independent predictors of MINOCA. Multivariate regression analysis was also performed to identify independent predictors of MINOCA. We identified 139 patients with MINOCA and 142 patients with medically managed obstructive ACS (M-ACS). Multivariate regression analysis also identified female sex and cancer as independent predictors of MINOCA with odds ratios of 5.57 and 3.01, respectively. MINOCA patients were significantly less likely to receive cardioprotective medications at admission and discharge, specifically aspirin, beta-blockers, ACE-I and statins, compared to those with M-ACS. While mortality was higher among M-ACS patients (0.0% vs. 3.6%; p = 0.03), no significant differences were noted for composite NACE, heart failure, stroke and major bleeding. MINOCA patients have similar outcomes to M-ACS. Despite this, we noted a discrepancy in the use of cardioprotective medications. We also identified female sex and cancer were independent predictors of MINOCA. This may represent a missed opportunity to prevent adverse events among patients with MINOCA. Large, randomised trials are required to provide more definitive evidence.
大多数先前的研究将非阻塞性冠状动脉心肌梗死(MINOCA)与通常需要血运重建的阻塞性急性冠状动脉综合征(ACS)进行了比较。然而,鉴于管理上的显著差异,这些研究存在治疗偏倚。本研究独特地比较了MINOCA患者与接受药物治疗的阻塞性ACS(M-ACS)人群的管理和结局。我们回顾性分析了黄金海岸大学医院收治的需要冠状动脉造影的ACS连续患者的登记数据,并确定了MINOCA和M-ACS患者。比较了基线特征、药物治疗和住院结局。住院结局包括复合NACE、心力衰竭、中风和大出血。还进行了多变量回归分析以确定MINOCA的独立预测因素。我们确定了139例MINOCA患者和142例接受药物治疗的阻塞性ACS(M-ACS)患者。多变量回归分析还确定女性和癌症是MINOCA的独立预测因素,优势比分别为5.57和3.01。与M-ACS患者相比,MINOCA患者在入院和出院时接受心脏保护药物治疗的可能性显著降低,特别是阿司匹林、β受体阻滞剂、ACE-I和他汀类药物。虽然M-ACS患者的死亡率较高(0.0%对3.6%;p = 0.03),但在复合NACE、心力衰竭、中风和大出血方面未观察到显著差异。MINOCA患者与M-ACS患者有相似的结局。尽管如此,我们注意到心脏保护药物的使用存在差异。我们还确定女性和癌症是MINOCA的独立预测因素。这可能代表了预防MINOCA患者不良事件的一个错失的机会。需要进行大型随机试验以提供更确凿的证据。